S Sakuma Selected Research

S Sakuma Research Topics

Disease

3	Neoplasms (Cancer) 09/2003 - 07/2000
3	Inflammation (Inflammations) 11/2001 - 09/2000
3	Malignant Fibrous Histiocytoma 03/2001 - 07/2000
2	Autoimmune Diseases (Autoimmune Disease) 06/2014 - 04/2001
2	Hypersensitivity (Allergy) 06/2014 - 11/2003
2	Neuroblastoma 05/2003 - 06/2001
2	Fibrosis (Cirrhosis) 05/2002 - 01/2001
2	Atopic Dermatitis (Atopic Eczema) 11/2001 - 06/2001
2	Neointima 05/2001 - 02/2000
2	Necrosis 02/2001 - 08/2000
1	Dermatitis 01/2009
1	Dental Fluorosis 01/2006
1	Neurofibrosarcoma (MPNST) 09/2003
1	Carcinogenesis 05/2003
1	Colorectal Neoplasms (Colorectal Cancer) 05/2003
1	Body Weight (Weight, Body) 05/2002
1	Hyperalgesia 10/2001
1	Arthritis (Polyarthritis) 10/2001
1	Histiocytic Sarcoma 07/2001
1	Rheumatoid Arthritis 04/2001
1	Infarction (Infarctions) 03/2001
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2001
1	Ischemia 03/2001
1	Cerebral Infarction 03/2001
1	Wounds and Injuries (Trauma) 01/2001
1	Kidney Diseases (Kidney Disease) 01/2001
1	Edema (Dropsy) 01/2001
1	Fever (Fevers) 10/2000
1	Fatigue 10/2000
1	Jaundice (Icterus) 10/2000
1	Nausea 10/2000
1	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2000
1	Hyperplasia 10/2000
1	Anorexia 10/2000
1	Anemia 10/2000
1	Adenocarcinoma 10/2000
1	Transfusion Reaction 10/2000
1	Hyperbilirubinemia 10/2000
1	Carcinoma (Carcinomatosis) 09/2000
1	Leukemia 03/2000
1	Wilms Tumor (Wilm's Tumor) 02/2000

Drug/Important Bio-Agent (IBA)

7	Tacrolimus (Prograf)FDA LinkGeneric 01/2009 - 03/2000
7	MidkineIBA 05/2003 - 02/2000
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2003 - 02/2000
4	Heparin (Liquaemin)FDA LinkGeneric 05/2003 - 02/2000
3	Monoclonal AntibodiesIBA 03/2001 - 08/2000
2	Ointments (Pastes)IBA 01/2009 - 06/2001
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2003 - 10/2000
2	Messenger RNA (mRNA)IBA 05/2003 - 10/2000
2	Cisplatin (Platino)FDA LinkGeneric 05/2002 - 02/2000
2	AntigensIBA 11/2001 - 03/2001
2	LipopolysaccharidesIBA 07/2001 - 02/2001
2	CytokinesIBA 06/2001 - 08/2000
2	Immunosuppressive Agents (Immunosuppressants)IBA 04/2001 - 08/2000
2	AntibodiesIBA 10/2000 - 07/2000
2	Proteins (Proteins, Gene)FDA Link 10/2000 - 02/2000
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 06/2014
1	bleselumabIBA 06/2014
1	FluoridesIBA 01/2006
1	Ophthalmic Solutions (Eye Drops)IBA 11/2003
1	Biological ProductsIBA 09/2003
1	Laminin (Merosin)IBA 09/2003
1	Nerve Growth Factor (NGF)IBA 09/2003
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 09/2003
1	pleiotrophin (HARP)IBA 05/2003
1	OligodeoxyribonucleotidesIBA 05/2003
1	Pharmaceutical PreparationsIBA 01/2002
1	Methotrexate (Mexate)FDA LinkGeneric 10/2001
1	Therapeutic UsesIBA 10/2001
1	Lysine (L-Lysine)FDA Link 06/2001
1	AutoantibodiesIBA 04/2001
1	Interleukin-6 (Interleukin 6)IBA 04/2001
1	Indicators and Reagents (Reagents)IBA 03/2001
1	Nerve Growth Factors (Neurotrophins)IBA 03/2001
1	Alcohol OxidoreductasesIBA 01/2001
1	Oxidoreductases (Dehydrogenase)IBA 01/2001
1	NADP (NADPH)IBA 01/2001
1	Muramidase (Lysozyme)IBA 01/2001
1	tranilastIBA 01/2001
1	Peptides (Polypeptides)IBA 01/2001
1	Anti-Idiotypic AntibodiesIBA 10/2000
1	IsoantibodiesIBA 10/2000
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2000
1	nitrosobis(2-oxopropyl)amine (NBOP)IBA 10/2000
1	CreatinineIBA 10/2000
1	NitrogenIBA 10/2000
1	BilirubinIBA 10/2000
1	Urea (Carbamide)FDA LinkGeneric 10/2000
1	Hemoglobins (Hemoglobin)IBA 10/2000
1	C-Reactive ProteinIBA 09/2000
1	InterleukinsIBA 08/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2000
1	Antirheumatic Agents (DMARD)IBA 08/2000
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2000
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2000
1	SteroidsIBA 03/2000

Therapy/Procedure

2	Therapeutics 06/2014 - 05/2003
1	Transplantation 06/2014